Ortho McNeil Neurologics To Promote Razadyne (Formerly Reminyl)
Executive Summary
Johnson & Johnson is changing the name of Reminyl (galantamine) to Razadyne in advance of the launch of an extended-release version of the Alzheimer's product
You may also be interested in...
Forest Sees “Moderate” Namenda Growth Opportunity In Mild Alzheimer’s
Forest expects approval of its Namenda sNDA for the treatment of mild-to-moderate Alzheimer's disease to generate a "modest uptick" in prescription volume in the second half of the year
Forest Sees “Moderate” Namenda Growth Opportunity In Mild Alzheimer’s
Forest expects approval of its Namenda sNDA for the treatment of mild-to-moderate Alzheimer's disease to generate a "modest uptick" in prescription volume in the second half of the year
Reminyl Name Change Gives J&J Fresh Message For Galantamine ER Launch
Janssen's name change for its Reminyl Alzheimer's products gives the company a fresh platform for promoting the galantamine extended-release formulation approved by FDA Dec. 22